Patents by Inventor Karsten Mader

Karsten Mader has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210401996
    Abstract: The present invention generally relates to controlled release of tetracycline antibiotics. Specifically, it relates to a complex comprising a tetracycline compound (TC) or a pharmaceutically acceptable salt, hydrate or solvate thereof and a divalent metal carboxylate; a pharmaceutical preparation comprising the complex, methods for manufacturing the complex and the pharmaceutical preparation, and a complex or a pharmaceutical preparation for use in a method for treatment of the human or animal body, in particular for therapy and/or prophylaxis of a bacterial infection; and/or wherein antibiotic activity is maintained over a prolonged period of time; and/or for the therapy and/or prophylaxis of an acute, chronic or recurrent periodontal disease.
    Type: Application
    Filed: October 29, 2019
    Publication date: December 30, 2021
    Inventors: Andreas KIESOW, Mirko BUCHHOLZ, Sandra SAREMBE, Karsten MÄDER, Martin KIRCHBERG, Sigrun EICK
  • Patent number: 8663692
    Abstract: The invention relates to drug-free or drug-loaded lipid particles of a mixed matrix made of solid and liquid lipids, and to a method for producing highly concentrated lipid particle dispersions of solid-liquid particles having a lipid content of from 30% to 95% or a solids content of from 30% to 95% (lipid and stabilizer), which in contrast to biamphipileic cremes are integer particles, and/or which upon dilution of the highly concentrated particle dispersions with the outer phase result in free-flowable particle dispersions.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: March 4, 2014
    Assignee: Pharmasol GmbH
    Inventors: Rainer H. Müller, Volkard Jenning, Karsten Mader, Andreas Lippacher
  • Patent number: 8202540
    Abstract: The invention relates to superfine microparticles and nanoparticles and a process for their gentle preparation with exclusion of water or minimization of water and/or exclusion of plasticizers and/or reduced temperature load, in which a matrix material is subjected to a high-pressure homogenization process in an anhydrous or water-poor medium and/or at low temperatures, preferably room temperature (20° C.) and in particular below the freezing point of water, which leads to a gentle particle reduction with minimization of the impairment of the chemical stability of the homogenized material.
    Type: Grant
    Filed: July 10, 2000
    Date of Patent: June 19, 2012
    Assignee: Abbott GmbH & Co., KG
    Inventors: Rainer H. Müller, Karsten Krause, Karsten Mäder
  • Patent number: 6814959
    Abstract: The invention relates to agents with UV radiation-absorbing and/or reflecting action comprising solid, polymorphic, crystal-line or partially crystalline lipid and/or polymer particles, for application to the skin, mucous membranes, scalp, and hair for protection against health-damaging UV radiation and for strengthening the natural skin barrier.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: November 9, 2004
    Assignee: PharmaSol GmbH
    Inventors: Rainer H. Müller, Sylvia Wissing, Karsten Mäder
  • Patent number: 5706805
    Abstract: The invention provides apparatus and methods for measuring oxygen tensions in biological systems utilizing physiologically acceptable paramagnetic material, such as India ink or carbon black, and electron paramagnetic resonance (EPR) oximetry. India ink is introduced to the biological system and exposed to a magnetic field and an electromagnetic field in the 1-2 GHz range. The EPR spectra is then measured at the biological system to determine oxygen concentration. The EPR spectra is determined by an EPR spectrometer that adjusts the resonator to a single resonator frequency to compensate for movements of the biological system, such as a human or animal. The biological system can also include other in vivo tissues, cells, and cell cultures to directly measure pO.sub.2 non-destructively. The paramagnetic material can be used non-invasively or invasively depending on the goals of the pO2 measurement.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 13, 1998
    Assignee: Trustees of Dartmouth College
    Inventors: Harold M. Swartz, Fuminori Goda, Tadeusz Walczak, Ke Jian Liu, Karsten Mader